Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-010386)

Filing Details

Accession Number:: 0001104659-21-010386
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-01 19:54:25
Reporting Period:: 2021-01-28

Accepted Time:: 2021-02-01 19:54:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1818844	Virios Therapeutics Inc.	VIRI	Pharmaceutical Preparations (2834)	854314201

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1826115	William Pridgen	C/O Virios Therapeutics, Inc. 44 Milton Avenue Alpharetta GA 30009		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-01-28	801	$7.80	727,993	No	4	M	Direct
Common Stock	Acquisiton	2021-01-29	3,500	$7.47	3,500	No	4	P	Indirect	401(k) Account

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	P	Indirect	401(k) Account

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Disposition	2021-01-28	801	$0.00	801	$7.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-12-16	2021-01-20	No	4	M	Direct

Footnotes

The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.
The Reporting Person provided notice of exercise to the Issuer on January 20, 2021 and the Company authorized the issuance of the shares pursuant to such exercise on January 28, 2020.